Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Joint Metastasis Research Society-AACR Conference on Metastasis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 27, 522-525, March 1, 1967]
© 1967 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pine, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pine, M. J.

Intracellular Protein Breakdown in the L1210 Ascites Leukemia1

Martin J. Pine

Department of Experimental Therapeutics, Roswell Park Memorial Institute, Buffalo, New York 14203

The endogenous catabolism of the cell protein of the L1210 mouse ascites tumor has been estimated from its in vitro breakdown to free amino acid after pulse labeling in vivo with leucine-1-14C. Two general protein classes are distinguishable according to their breakdown: an unstable population representing one-fifteenth of the cell protein and with an average half-life of several hours, and the stable remaining protein with a uniform breakdown one-fifth the cumulative rate of the unstable class. Treated as a parameter of growth, the cumulative turnover of the unstable class requires the expenditure of 5% of the biosynthetic capacity of the cell per hour, and comprises one-third of the total cellular protein turnover of 1.5%/hour.

None of a variety of inhibitory agents administered in vivo or in vitro selectively stimulates or inhibits the cumulative breakdown rate. However, the selection of proteolyzable cellular substrates varies with the physiologic state of the cell. After treatment of the tumor with chemotherapeutic agents, breakdown is expanded to a broader spectrum of cellular substrates than are proteolyzed in growth.

1 This work was supported by Grant CA-07777 from the National Cancer Institute, NIH, USPHS.

Received 6/23/66. Accepted 10/24/66.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1967 by the American Association for Cancer Research.